Cargando…

Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism

CONTEXT: Primary aldosteronism (PA) confers an increased risk of cardiovascular disease (CVD), independent of blood pressure. Animal models have shown that aldosterone accelerates atherosclerosis through proinflammatory changes in innate immune cells; human data are scarce. OBJECTIVE: The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijden, Charlotte D C C, Smeets, Esther M M, Aarntzen, Erik H J G, Noz, Marlies P, Monajemi, Houshang, Kersten, Simone, Kaffa, Charlotte, Hoischen, Alexander, Deinum, Jaap, Joosten, Leo A B, Netea, Mihai G, Riksen, Niels P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105350/
https://www.ncbi.nlm.nih.gov/pubmed/31875423
http://dx.doi.org/10.1210/clinem/dgz306
_version_ 1783512382506532864
author van der Heijden, Charlotte D C C
Smeets, Esther M M
Aarntzen, Erik H J G
Noz, Marlies P
Monajemi, Houshang
Kersten, Simone
Kaffa, Charlotte
Hoischen, Alexander
Deinum, Jaap
Joosten, Leo A B
Netea, Mihai G
Riksen, Niels P
author_facet van der Heijden, Charlotte D C C
Smeets, Esther M M
Aarntzen, Erik H J G
Noz, Marlies P
Monajemi, Houshang
Kersten, Simone
Kaffa, Charlotte
Hoischen, Alexander
Deinum, Jaap
Joosten, Leo A B
Netea, Mihai G
Riksen, Niels P
author_sort van der Heijden, Charlotte D C C
collection PubMed
description CONTEXT: Primary aldosteronism (PA) confers an increased risk of cardiovascular disease (CVD), independent of blood pressure. Animal models have shown that aldosterone accelerates atherosclerosis through proinflammatory changes in innate immune cells; human data are scarce. OBJECTIVE: The objective of this article is to explore whether patients with PA have increased arterial wall inflammation, systemic inflammation, and reprogramming of monocytes. DESIGN: A cross-sectional cohort study compared vascular inflammation on 2’-deoxy-2’-(18F)fluoro-D-glucose; ((18)F-FDG) positron emission tomography–computed tomography, systemic inflammation, and monocyte phenotypes and transcriptome between PA patients and controls. SETTING: This study took place at Radboudumc and Rijnstate Hospital, the Netherlands. PATIENTS: Fifteen patients with PA and 15 age-, sex-, and blood pressure-matched controls with essential hypertension (EHT) participated. MAIN OUTCOME MEASURES AND RESULTS: PA patients displayed a higher arterial (18)F-FDG uptake in the descending and abdominal aorta (P < .01, P < .05) and carotid and iliac arteries (both P < .01). In addition, bone marrow uptake was higher in PA patients (P < .05). Although PA patients had a higher monocyte-to-lymphocyte ratio (P < .05), systemic inflammatory markers, cytokine production capacity, and transcriptome of circulating monocytes did not differ. Monocyte-derived macrophages from PA patients expressed more TNFA; monocyte-derived macrophages of healthy donors cultured in PA serum displayed increased interleukin-6 and tumor necrosis factor-α production. CONCLUSIONS: Because increased arterial wall inflammation is associated with accelerated atherogenesis and unstable plaques, this might importantly contribute to the increased CVD risk in PA patients. We did not observe inflammatory reprogramming of circulating monocytes. However, subtle inflammatory changes are present in the peripheral blood cell composition and monocyte transcriptome of PA patients, and in their monocyte-derived macrophages. Most likely, arterial inflammation in PA requires interaction between various cell types.
format Online
Article
Text
id pubmed-7105350
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71053502020-04-06 Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism van der Heijden, Charlotte D C C Smeets, Esther M M Aarntzen, Erik H J G Noz, Marlies P Monajemi, Houshang Kersten, Simone Kaffa, Charlotte Hoischen, Alexander Deinum, Jaap Joosten, Leo A B Netea, Mihai G Riksen, Niels P J Clin Endocrinol Metab Clinical Research Article CONTEXT: Primary aldosteronism (PA) confers an increased risk of cardiovascular disease (CVD), independent of blood pressure. Animal models have shown that aldosterone accelerates atherosclerosis through proinflammatory changes in innate immune cells; human data are scarce. OBJECTIVE: The objective of this article is to explore whether patients with PA have increased arterial wall inflammation, systemic inflammation, and reprogramming of monocytes. DESIGN: A cross-sectional cohort study compared vascular inflammation on 2’-deoxy-2’-(18F)fluoro-D-glucose; ((18)F-FDG) positron emission tomography–computed tomography, systemic inflammation, and monocyte phenotypes and transcriptome between PA patients and controls. SETTING: This study took place at Radboudumc and Rijnstate Hospital, the Netherlands. PATIENTS: Fifteen patients with PA and 15 age-, sex-, and blood pressure-matched controls with essential hypertension (EHT) participated. MAIN OUTCOME MEASURES AND RESULTS: PA patients displayed a higher arterial (18)F-FDG uptake in the descending and abdominal aorta (P < .01, P < .05) and carotid and iliac arteries (both P < .01). In addition, bone marrow uptake was higher in PA patients (P < .05). Although PA patients had a higher monocyte-to-lymphocyte ratio (P < .05), systemic inflammatory markers, cytokine production capacity, and transcriptome of circulating monocytes did not differ. Monocyte-derived macrophages from PA patients expressed more TNFA; monocyte-derived macrophages of healthy donors cultured in PA serum displayed increased interleukin-6 and tumor necrosis factor-α production. CONCLUSIONS: Because increased arterial wall inflammation is associated with accelerated atherogenesis and unstable plaques, this might importantly contribute to the increased CVD risk in PA patients. We did not observe inflammatory reprogramming of circulating monocytes. However, subtle inflammatory changes are present in the peripheral blood cell composition and monocyte transcriptome of PA patients, and in their monocyte-derived macrophages. Most likely, arterial inflammation in PA requires interaction between various cell types. Oxford University Press 2019-12-25 /pmc/articles/PMC7105350/ /pubmed/31875423 http://dx.doi.org/10.1210/clinem/dgz306 Text en © Endocrine Society 2019. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research Article
van der Heijden, Charlotte D C C
Smeets, Esther M M
Aarntzen, Erik H J G
Noz, Marlies P
Monajemi, Houshang
Kersten, Simone
Kaffa, Charlotte
Hoischen, Alexander
Deinum, Jaap
Joosten, Leo A B
Netea, Mihai G
Riksen, Niels P
Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
title Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
title_full Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
title_fullStr Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
title_full_unstemmed Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
title_short Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
title_sort arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105350/
https://www.ncbi.nlm.nih.gov/pubmed/31875423
http://dx.doi.org/10.1210/clinem/dgz306
work_keys_str_mv AT vanderheijdencharlottedcc arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT smeetsesthermm arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT aarntzenerikhjg arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT nozmarliesp arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT monajemihoushang arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT kerstensimone arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT kaffacharlotte arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT hoischenalexander arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT deinumjaap arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT joostenleoab arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT neteamihaig arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism
AT riksennielsp arterialwallinflammationandincreasedhematopoieticactivityinpatientswithprimaryaldosteronism